Before Header Navigation

  • Healthcare Professionals
  • Existing Patients
  • Find clinics worldwide
United Kingdom
Choose your country or region in order to display more relevant content.
Select
Other country or region
Continue
Home
Menu
Close

Main navigation - US

  • Home
  • About Allurion
  • Meet the Team
  • Our Story
  • Careers
  • Healthcare Professionals
  • Existing Patients
  • Find clinics worldwide
Ip Address
18.221.242.128
Country
United States of America
Country Code
US

Site map

Menu
Close

Main navigation - US

  • Home
  • About Allurion
  • Meet the Team
  • Our Story
  • Careers
  • Healthcare Professionals
  • Existing Patients
  • Find clinics worldwide

References

  • *As with any medical solution, results may vary from one patient to another, and some patients may not respond to treatment. Please consult a doctor to carefully evaluate the risks and benefits before making your decision.
  • **Some patients may experience earlier deflation of the Allurion Balloon. The removal of the Allurion Balloon may, in very rare cases, require an endoscopic or surgical intervention. In rare cases, instead of being expelled through the digestive tract, the empty balloon may be vomited out.
  • ***Eligibility for the placement of an Allurion Balloon will be assessed by a certified doctor after an initial consultation and a careful review of your medical history. In the case of an extended Allurion Program, your eligibility is reassessed before each placement to ensure you continue to meet the required conditions.
  1. R. Ienca et al. The procedureless ellipse gastric balloon program: Multicenter experience in 1770 consecutive patients. Obes surg. 2020;30(9):3354-3362. Multicenter, prospective, non-randomized, open registry study conducted in patients with overweight or obesity from January 2016 to June 2019 in 19 international obesity centers participating in the study. A total of 1,770 patients with an average BMI of 34.4 ± 5.3 kg/m2 at baseline underwent treatment with the Elipse swallowable gastric balloon, with a monthly visit and a total follow-up of 4 months. 63 patients (3.6%) did not complete the program, and the balloon was removed before 4 months due to intolerance or other adverse effects.
  2. World Health Organization – Key facts on Obesity and overweight (who.int).
  3. European survey finds over three-quarters of adults with obesity have attempted to lose weight in the past year, but most have been unsuccessful – EASO.
  4. This information is extracted from the instructions for use of the Allurion Gastric Balloon System. Version number CS137-02-ENG. If you have any questions regarding this document, please consult your doctor.

About Allurion

At Allurion, we seek to end obesity globally, helping our patients to live fuller, longer lives. We aim to be the catalyst for weight loss for life. A lasting weight loss program that will guide your weight loss for life. We have devised a program that combines medical, digital, and nutritional approaches, with the help of an entire team dedicated to jumpstarting your weight loss journey and aiding you in forming lifelong healthy habits.

The Allurion Balloon is not currently approved in the USA.

Footer

  • Meet The Team
  • Our Story
  • Careers
  • Find a Clinic
  • Blog
  • Our Patents
  • Privacy Policy
  • Quality and Risk
  • Terms of Use
  • Site Map
  • Investors
  • Become a Provider
© Allurion 2025

Social links

  • Facebook
  • YouTube
  • Instagram
  • LinkedIn

click me

Chat with Ally